vimarsana.com

Recursion Map News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Salt lake cityUnited statesUnited kingdomMeredith brown tuttleExchange commissionRegulatory affairsEuropean unionEuropean commissionDrug administrationRecursion orphan drug designationVice presidentOrphan drug designationOrphan drugFast trackRecursion operating systemRecursion data

Recursion is Granted EU Orphan Drug Designation for REC-4881 for the Potential Treatment of Familial Adenomatous Polyposis

SALT LAKE CITY, July 21, 2022 /PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the

Salt lake cityUnited statesUnited kingdomMeredith brown tuttleExchange commissionRegulatory affairsEuropean unionEuropean commissionDrug administrationRecursion orphan drug designationVice presidentOrphan drug designationOrphan drugFast trackRecursion operating systemRecursion data

Recursion to Participate in Upcoming Investor Conferences

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.

Salt lake cityUnited statesHealthcare conferenceSachs annual global healthcare conferenceBiotech conferenceRecursion operating systemRecursion dataRecursion mapSan francisco bay

Recursion Provides Business Updates and Reports First Quarter 2022 Financial Results

/PRNewswire/ Recursion (Nasdaq: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today reported business.

United statesSalt lake cityRyan kellyVirgin hyperloopJared allenbachMarie evangelistaDevelopment expensesAmerican association for cancer researchRecursion pharmaceuticals incDrug administrationGoldman sachsFast trackAmerican associationCancer researchGenentech collaborationAdministrative expenses

Recursion to Participate in Upcoming Investor Conference

/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.

United statesSalt lake cityRecursion operating systemRecursion dataRecursion mapSan francisco bay

vimarsana © 2020. All Rights Reserved.